JMDC Inc. (TSE:4483) agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million on December 28, 2023. JMDC Inc. (TSE:4483) will acquire 0.11 million shares of Cancer Scan Co., Ltd. The total assets were ¥ 2695 million, net assets were ¥ 2,097 million, revenue was ¥ 4,177 million, operating profit was ¥ 696 million and net income was ¥ 454 million for year ending May 31, 2023 of Cancer Scan Co., Ltd. The deal is expected to be closed on January 31, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,031 JPY | +6.35% | -5.58% | -28.90% |
May. 08 | JMDC to Pay Final Dividend of 14 Yen Per Share in June | MT |
May. 07 | JMDC's Profit Up 8% in Fiscal 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.90% | 1.19B | |
+19.39% | 4.51B | |
-20.16% | 2.31B | |
+20.54% | 1.84B | |
-8.20% | 1.64B | |
+1.22% | 1.55B | |
-21.10% | 1.47B | |
-8.38% | 1.14B | |
-14.79% | 925M | |
+118.67% | 692M |
- Stock Market
- Equities
- 4483 Stock
- News JMDC Inc.
- JMDC Inc. agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million.